Editorial Comment: Prostate‐Specific Antigen Dynamics and Bone Predominance as Predictors of Efficacy in Radium‐223 Treatment for Castration‐Resistant Prostate Cancer

Documenti analoghi

• Prognostic Impact of Time to Castration Resistance on Overall Survival in Patients With Metastatic Castration‐Sensitive Prostate Cancer
  di: Hiroaki Iwamoto, et al.
  Pubblicazione: (2025)
• Editorial Comment on “Outcomes and Safety Profile of Repeated Progressive Site‐Directed Therapy for Patients With Oligometastatic Castration‐Resistant Prostate Cancer”
  di: Rihito Aizawa, et al.
  Pubblicazione: (2025)
• Prognostic Significance of Radiographic Progression at Metastatic Castration‐Resistant Prostate Cancer Diagnosis
  di: Hiroaki Iwamoto, et al.
  Pubblicazione: (2026)
• Myosteatosis Predicts Poor Prognosis in Patients With Castration‐Resistant Prostate Cancer Treated With Enzalutamide
  di: Tomohiro Kanaki, et al.
  Pubblicazione: (2026)
• Editorial Comment on "Frontiers of Ultrasound Technology in Prostate Cancer Treatment"
  di: Hiroshi Hirata
  Pubblicazione: (2025)